Wang Tianai, Hu Mengjie, Gong Cheng, Wu Tiangen, Zhang Cheng, Liu Zhisu, Pan Dingyu, Li Zhen
Objective To investigate the short-term efficacy and impact of bariatric surgery on super-obesity (SO) patients. Methods Clinical data of 65 SO patients with the body mass index(BMI)≥50 kg/m² who underwent bariatric metabolic surgery at Surgery Center for Bariatric & Metabolic Diseases, Zhongnan Hospital of Wuhan University, between March 2019 and July 2024 were retrospectively collected. Preoperative and postoperative(1,3,6,and 12 months postoperatively) parameters were recorded and analyzed, including BMI, percentage of excess weight loss(%EWL),percentage of total weight loss (%TWL),glucose metabolism, lipid metabolism, liver and kidney function, and uric acid levels. Results All 65 SO patients successfully underwent bariatric surgery without conversion to open surgery, postoperative bleeding, gastric leakage, pulmonary infections, or perioperative mortality. Among them, 39 patients underwent laparoscopic sleeve gastrectomy (LSG), and 26 patients underwent laparoscopic sleeve gastrectomy+jejunojejunal bypass (LSG+JJB). During the 6-month postoperative follow-up, patients in both groups showed significant improvements in BMI, glucose metabolism, lipid metabolism, liver and kidney function(all P<0.05). In details,BMI in the LSG group decreased from 53.68±2.69 kg/m2 before surgery to 38.89±3.57 kg/m2 at 6 months postoperatively;BMI in the LSG+JJB group decreased from 52.83±2.94 kg/m2 before surgery to 38.22±3.64 kg/m2 at 6 months postoperatively. The 2-hour postprandial glucose in the LSG group decreased from 9.96±4.08 mmol/L before surgery to 6.45±2.04 mmol/L at 6 months postoperatively; 2-hour postprandial glucose in the LSG+JJB group decreased from 11.4±5.61 mmol/L before surgery to 6.56±2.94 mmol/L at 6 months postoperatively.Uric acid in the LSG group decreased from 508.95±133.89 μmol/L before surgery to 389.11±102.13 μmol/L at 6 months postoperatively; Uric acid in the LSG+JJB group decreased from 504.88±118.64 μmol/L before surgery to 420.65±72.21 μmol/L at 6 months postoperatively. Conclusion Bariatric surgery has a significant short-term effect in the treatment of SO patients, and can effectively improve and cure obesity-related metabolic diseases.